Citi Downgrades R1 RCM Inc (RCM) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- CoreWeave stock drops on dilution fears and debt concerns
- Wall Street ends lower, off record highs, as Treasury yields climb
RCM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of R1 RCM to TowerBrook Capital Partners and Clayton, Dubilier & Rice
August 1, 2024 4:57 PM EDTMONSEY, N.Y., Aug. 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the sale of R1 RCM, Inc. (Nasdaq: RCM) (RCM) for $14.30 per share in cash to TowerBrook Capital Partners (TowerBrook) and Clayton, Dubilier & Rice (CDR). The sales price is below the price targets for RCM of virtually every Wall Street analyst (source: TipRanks).
If you remain an RCM shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no... More
RCM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of R1 RCM to TowerBrook Capital Partners and Clayton, Dubilier & Rice
August 1, 2024 4:56 PM EDTMONSEY, N.Y., Aug. 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the sale of R1 RCM, Inc. (Nasdaq: RCM) (RCM) for $14.30 per share in cash to TowerBrook Capital Partners (TowerBrook) and Clayton, Dubilier & Rice (CDR). The sales price is below the price targets for RCM of virtually every Wall Street analyst (source: TipRanks).
If you remain an RCM shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no... More



